Founded in 2018, O2h Ventures invests in early-stage emerging life science and tech companies that address human health. The firm funds the development of novel therapeutic treatments, builds new services and tools offerings throughout the biotech ecosystem, and spurs the creation of software and artificial intelligence that will change healthcare. The team behind O2h Ventures has been actively involved in the biotech community for over 20 years, holding various board and industry positions. The firm operates from their proprietary 2.7 acre Mill SciTech Park where they are developing a unique model for incubating small life science companies. For more information or to invest in the fund, visit their website.